Evidence map›Paper›PMID 39922261›Full record

ArticleEnvironmental research2025

Maternal organophosphate esters and sex steroid hormones in mid-pregnancy.

Megan C Hansel, Katherine A Lubina, Troy A Roepke, Pamela Ohman-Strickland, Kurunthachalam Kannan, Christina Wang, Richard K Miller, Thomas G O'Connor, Zorimar Rivera-Núñez, Emily S Barrett

Abstract read
In one paragraph

Article in Environmental research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Megan C HanselDepartment of Biostatistics and Epidemiology, Rutgers School of Public Health, Piscataway, NJ, USA.
Katherine A LubinaDepartment of Biostatistics and Epidemiology, Rutgers School of Public Health, Piscataway, NJ, USA.
Troy A RoepkeDepartment of Animal Sciences, School of Environmental & Biological Sciences, Rutgers, The State University of New Jersey, New Brunswick, NJ, USA.
Pamela Ohman-StricklandDepartment of Biostatistics and Epidemiology, Rutgers School of Public Health, Piscataway, NJ, USA.
Kurunthachalam KannanWadsworth Center, New York State Department of Health, Albany, NY, 12237, USA.
Christina WangClinical and Translational Science Institute, The Lundquist Institute at Harbor -UCLA Medical Center, Torrance, CA, USA.
Richard K MillerDepartment of Obstetrics and Gynecology, University of Rochester Medical Center, Rochester, NY, USA.
Thomas G O'ConnorDepartment of Obstetrics and Gynecology, University of Rochester Medical Center, Rochester, NY, USA; Departments of Psychiatry, Psychology, Neuroscience, University of Rochester, NY, USA.
Zorimar Rivera-NúñezDepartment of Biostatistics and Epidemiology, Rutgers School of Public Health, Piscataway, NJ, USA; Environmental and Occupational Health Sciences Institute, Rutgers University, Piscataway, NJ, USA.
Emily S BarrettDepartment of Biostatistics and Epidemiology, Rutgers School of Public Health, Piscataway, NJ, USA; Department of Obstetrics and Gynecology, University of Rochester Medical Center, Rochester, NY, USA; Environmental and Occupational Health Sciences Institute, Rutgers University, Piscataway, NJ, USA. Electronic address: esb104@eohsi.rutgers.edu.

Funding

UCLA Clinical Translational Science InstituteUL1TR001881 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ARLEEN F. BROWN, ARASH NAEIM · 2016 to 2026
$118.1M
Translational Research Support CoreP30ES005022 · NIEHS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI Emily S Barrett · 1988 to 2026
$47.4M
Pre- and Postnatal Exposure Periods for Child Health: Common Risks and Shared MechanismsUH3OD023349 · OD · UNIVERSITY OF ROCHESTER · PI Emily S Barrett, Richard Kermit Miller · 2018 to 2026
$15.9M
Pre- and Postnatal Exposure Periods for Child Health: Common Risks and Shared MechanismsUG3OD023349 · OD · UNIVERSITY OF ROCHESTER · PI BARRETT, EMILY S, MILLER, RICHARD KERMIT · 2016 to 2024
$7.0M
Understanding Prenatal Signals and Infant Development (UPSIDE)R01HD083369 · NICHD · UNIVERSITY OF ROCHESTER · PI BARRETT, EMILY S · 2015 to 2019
$2.6M
NCATS NIH HHS UL1 TR001881NICHD NIH HHS R01 HD083369NIEHS NIH HHS P30 ES005022NIH HHS UG3 OD023349NIH HHS UH3 OD023349
6 · The paper itself

Abstract

BACKGROUND/

aimsOrganophosphate esters (OPEs) are synthetic chemicals used in consumer products as flame retardants and plasticizers. OPEs are potential endocrine disruptors, but little is known regarding gestational OPE exposure and maternal sex steroid hormones in human pregnancy.

methodsUnderstanding Pregnancy Signals and Infant Development (UPSIDE) cohort participants (n=265) provided biospecimens and completed questionnaires in each trimester. In second trimester samples, we measured urinary OPE metabolite concentrations using HPLC-MS/MS. In second and third trimester serum samples, we measured sex steroids (total testosterone [TT], free testosterone, estrone [E1], estradiol [E2], and estriol [E3]) using LC-MS/MS. We fitted linear regression and linear mixed models examining each log-transformed, specific gravity-adjusted OPE metabolite in relation to sex steroid concentrations, adjusting for covariates. Three OPEs with >70% detection were considered continuously; six less prevalent metabolites were dichotomized (above vs below lower limit of detection). Secondary models were fit for male and female fetuses, separately. Results are shown as % difference in hormone levels.

resultsPercent detection of OPEs ranged from 26% to 100%. Diphenyl phosphate (DPHP) had the highest concentration (median 0.9 ng/mL). Across trimesters 2 and 3, a log-unit increase in dibutyl phosphate/di-isobutyl phosphate (DBUP/DIBP) was associated with lower TT (%Δ = -6.6, 95%CI: 11.5, -1.5), E1 (%Δ = -5.6, 95%CI: 10.8, -0.1), and E2 (%Δ = -5.3, 95%CI: 8.2, -2.3). Compared to those with non-detectable levels, participants with detectable bis(methylphenyl) phosphate (BMPP) had lower E3 (%Δ = -45.9, 95%CI: 67.9, -8.9) and participants with detectable bis(2-chloroethyl) phosphate (BCETP) had lower E2 (%Δ = -1.4, 95%CI: 2.4, -0.4). Numerous associations were observed in trimesters 2 and 3, individually. We observed several differences by fetal sex that varied in magnitude and direction.

conclusionOPEs may act as endocrine disruptors by altering maternal sex steroid hormones during pregnancy, with some differences by fetal sex. Further research is needed to understand implications for maternal and child health.

Indexed as

Endocrine DisruptorsEstersGonadal Steroid HormonesMaternal ExposureOrganophosphatesAdultCohort StudiesFemaleHumansMalePregnancyPregnancy Trimester, SecondYoung AdultEndocrine DisruptorsEstersGonadal Steroid HormonesOrganophosphatesAndrogensEstrogensOrganophosphate estersPregnancySex steroid hormones

Identifiers

PMID39922261
PMCPMC11959487

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.